Saisree Reddy Adla Jala
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Saisree Reddy Adla Jala has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Abinash Mahapatro
SIU School of Medicine, Springfield, IL, USA
4 shared publications - Kavya Priya Somu
Department of Internal Medicine, Centinela Hospital Medical Center, Inglewood, CA, USA
4 shared publications - Ehsan Amini-Salehi
Gastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran
3 shared publications - Herby Jeanty
The Brooklyn Hospital Center, Brooklyn, NY
3 shared publications - Ali Fatehi Hassanabad
Section of Cardiac Surgery, Columbia University Vagelos College of Physicians and Surgeons, New York City, New York, USA
2 shared publications - Maryam Jafari
Student Research Committee, School of Medicine, Anzali International Campus, Guilan University of Medical Sciences, Rasht, Iran
2 shared publications
Latest Publications
- Open Access
- 4 September 2026
- Published by Springer Nature in Egyptian Journal of Radiology and Nuclear Medicine
- Vol. 57 (1) , 183
Deep learning-based segmentation of abdominal aortic aneurysm: a systematic review and meta-analysis of performance and clinical applicability
Background: Abdominal aortic aneurysm (AAA) management relies heavily on imaging for surveillance, treatment planning, and follow-up. Deep learning (DL)-based segmentation may improve the efficiency and reproducibility of AAA image analysis; however, reported performance varies across studies. This study aimed to systematically review and quantitatively summarize the performance of DL models for AAA-related segmentation. Methods: PubMed, Embase, Scopus, and Web of Science were searched for studies applying DL to AAA imaging in adults and reporting Dice score or intersection-over-union (IoU) as segmentation metrics. Each DL model evaluated on a held-out test set was treated as a separate model-level observation. Random-effects meta-analyses were used to pool Dice score and IoU. Subgroup analyses were performed by imaging modality, model category, and input dimensionality, and additional analyses provided structure-specific estimates for aneurysm sac, intraluminal thrombus (ILT), lumen, and EVAR-related segmentations. Results: Across all targets, overall segmentation performance was 0.81 (95% CI 0.78–0.83) for Dice score and 0.72 (95% CI 0.67–0.77) for IoU. In subgroup analyses by model category, pooled Dice scores were 0.83 (95% CI 0.80–0.86) for U-Net family models, 0.82 (95% CI 0.77–0.86) for transformer or hybrid models, and 0.76 (95% CI 0.72–0.81) for other convolutional neural networks. By imaging modality, Dice scores were 0.87 (95% CI 0.84–0.89) for contrast-enhanced CT (CECT), 0.83 (95% CI 0.78–0.88) for non-contrast CT (NCCT), 0.84 (95% CI 0.81–0.87) for MRI, 0.78 (95% CI 0.74–0.82) for CT angiography (CTA), and 0.95 (95% CI 0.92–0.98) for X-ray. IoU subgroup analyses showed broadly similar patterns by modality and model category. In structure-specific analyses, aneurysm sac segmentation achieved a pooled Dice of 0.87 (95% CI 0.85–0.89) and IoU of 0.80 (95% CI 0.68–0.93); ILT segmentation reached 0.72 (95% CI 0.62–0.81) and 0.67 (95% CI 0.57–0.77); lumen segmentation 0.84 (95% CI 0.73–0.95) and 0.92 (95% CI 0.80–1.00); and EVAR-related targets 0.76 (95% CI 0.67–0.86) and 0.66 (95% CI 0.55–0.77) for Dice and IoU, respectively. Conclusions: DL-based models demonstrate good segmentation performance for the AAA sac and lumen, indicating clinically acceptable accuracy for applications such as volumetric surveillance and surgical planning. Performance for ILT and EVAR-related structures is more variable, suggesting that human oversight remains advisable for these targets in clinical practice. These findings support the use of DL-based segmentation in research and highlight its potential for selected clinical applications. However, the evidence base remains heterogeneous and is derived from a limited number of studies, with most models lacking external validation. Larger, standardized, multicentre evaluations with robust external validation are needed to confirm and refine these estimates.
- 4 September 2026
- Published by Springer Nature in Egyptian Journal of Radiology and Nuclear Medicine
- Vol. 57 (1) , 183
Open AccessDeep learning-based segmentation of abdominal aortic aneurysm: a systematic review and meta-analysis of performance and clinical applicability
Background: Abdominal aortic aneurysm (AAA) management relies heavily on imaging for surveillance, treatment planning, and follow-up. Deep learning (DL)-based segmentation may improve the efficiency and reproducibility of AAA image analysis; however, reported performance varies across studies. This study aimed to systematically review and quantitatively summarize the performance of DL models for AAA-related segmentation. Methods: PubMed, Embase, Scopus, and Web of Science were searched for studies applying DL to AAA imaging in adults and reporting Dice score or intersection-over-union (IoU) as segmentation metrics. Each DL model evaluated on a held-out test set was treated as a separate model-level observation. Random-effects meta-analyses were used to pool Dice score and IoU. Subgroup analyses were performed by imaging modality, model category, and input dimensionality, and additional analyses provided structure-specific estimates for aneurysm sac, intraluminal thrombus (ILT), lumen, and EVAR-related segmentations. Results: Across all targets, overall segmentation performance was 0.81 (95% CI 0.78–0.83) for Dice score and 0.72 (95% CI 0.67–0.77) for IoU. In subgroup analyses by model category, pooled Dice scores were 0.83 (95% CI 0.80–0.86) for U-Net family models, 0.82 (95% CI 0.77–0.86) for transformer or hybrid models, and 0.76 (95% CI 0.72–0.81) for other convolutional neural networks. By imaging modality, Dice scores were 0.87 (95% CI 0.84–0.89) for contrast-enhanced CT (CECT), 0.83 (95% CI 0.78–0.88) for non-contrast CT (NCCT), 0.84 (95% CI 0.81–0.87) for MRI, 0.78 (95% CI 0.74–0.82) for CT angiography (CTA), and 0.95 (95% CI 0.92–0.98) for X-ray. IoU subgroup analyses showed broadly similar patterns by modality and model category. In structure-specific analyses, aneurysm sac segmentation achieved a pooled Dice of 0.87 (95% CI 0.85–0.89) and IoU of 0.80 (95% CI 0.68–0.93); ILT segmentation reached 0.72 (95% CI 0.62–0.81) and 0.67 (95% CI 0.57–0.77); lumen segmentation 0.84 (95% CI 0.73–0.95) and 0.92 (95% CI 0.80–1.00); and EVAR-related targets 0.76 (95% CI 0.67–0.86) and 0.66 (95% CI 0.55–0.77) for Dice and IoU, respectively. Conclusions: DL-based models demonstrate good segmentation performance for the AAA sac and lumen, indicating clinically acceptable accuracy for applications such as volumetric surveillance and surgical planning. Performance for ILT and EVAR-related structures is more variable, suggesting that human oversight remains advisable for these targets in clinical practice. These findings support the use of DL-based segmentation in research and highlight its potential for selected clinical applications. However, the evidence base remains heterogeneous and is derived from a limited number of studies, with most models lacking external validation. Larger, standardized, multicentre evaluations with robust external validation are needed to confirm and refine these estimates.
- Open Access
- 27 August 2026
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (10) , 6641-6653
The triglyceride-glucose index as a predictor of cardiovascular disease: an umbrella review of meta-analyses
Background: The triglyceride-glucose (TyG) index has gained recognition as a tool for assessing cardiovascular disease risk. This umbrella review synthesized findings from multiple meta-analyses examining the association between the TyG index and cardiovascular outcomes. Methods: In this umbrella review of meta-analyses, we followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Results: A higher TyG index was associated with increased odds of arterial stiffness [categorical: odds ratio (OR) = 1.83, 95% confidence interval (CI): 1.55–2.17, P < 0.01; I 2 = 68%; per 1-unit increase: OR = 1.51, 95% CI: 1.35–1.69, P < 0.01; I 2 = 82%]; coronary artery stenosis (OR = 3.49, 95% CI: 1.71–7.12, P < 0.01; I 2 = 0%); coronary artery calcification (CAC) (highest vs. lowest: OR = 1.66, 95% CI: 1.51–1.82, P < 0.01; I 2 = 0%; continuous: OR = 1.73, 95% CI: 1.36–2.20, P < 0.01; I 2 = 51%); CAC progression (categorical: OR = 1.66, 95% CI: 1.21–2.27, P < 0.01; I 2 = 0%; continuous: OR = 1.47, 95% CI: 1.29–1.68, P < 0.01; I 2 = 41%); and atrial fibrillation (AF) (categorical: OR = 1.98, 95% CI: 1.35–2.91, P < 0.01; I 2 = 92%; continuous: OR = 1.80, 95% CI: 1.50–2.17, P < 0.01; I 2 = 88%). Conclusion: Current meta-analytic evidence suggests that higher TyG index values are associated with several adverse cardiovascular outcomes. However, substantial heterogeneity and the generally low methodological quality of the included meta-analyses limit confidence in the magnitude and clinical applicability of these associations. The TyG index may serve as an adjunctive cardiovascular risk marker, but further high-quality prospective validation is required before routine clinical implementation.
- 27 August 2026
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (10) , 6641-6653
Open AccessThe triglyceride-glucose index as a predictor of cardiovascular disease: an umbrella review of meta-analyses
Background: The triglyceride-glucose (TyG) index has gained recognition as a tool for assessing cardiovascular disease risk. This umbrella review synthesized findings from multiple meta-analyses examining the association between the TyG index and cardiovascular outcomes. Methods: In this umbrella review of meta-analyses, we followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Results: A higher TyG index was associated with increased odds of arterial stiffness [categorical: odds ratio (OR) = 1.83, 95% confidence interval (CI): 1.55–2.17, P < 0.01; I 2 = 68%; per 1-unit increase: OR = 1.51, 95% CI: 1.35–1.69, P < 0.01; I 2 = 82%]; coronary artery stenosis (OR = 3.49, 95% CI: 1.71–7.12, P < 0.01; I 2 = 0%); coronary artery calcification (CAC) (highest vs. lowest: OR = 1.66, 95% CI: 1.51–1.82, P < 0.01; I 2 = 0%; continuous: OR = 1.73, 95% CI: 1.36–2.20, P < 0.01; I 2 = 51%); CAC progression (categorical: OR = 1.66, 95% CI: 1.21–2.27, P < 0.01; I 2 = 0%; continuous: OR = 1.47, 95% CI: 1.29–1.68, P < 0.01; I 2 = 41%); and atrial fibrillation (AF) (categorical: OR = 1.98, 95% CI: 1.35–2.91, P < 0.01; I 2 = 92%; continuous: OR = 1.80, 95% CI: 1.50–2.17, P < 0.01; I 2 = 88%). Conclusion: Current meta-analytic evidence suggests that higher TyG index values are associated with several adverse cardiovascular outcomes. However, substantial heterogeneity and the generally low methodological quality of the included meta-analyses limit confidence in the magnitude and clinical applicability of these associations. The TyG index may serve as an adjunctive cardiovascular risk marker, but further high-quality prospective validation is required before routine clinical implementation.
- Open Access
- 14 July 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (14) , 2103
Artificial Intelligence and Healthcare Policy: A Bibliometric Analysis of Global Research Trends
Background: Artificial intelligence is increasingly influencing health care and policy, yet the global research landscape linking artificial intelligence and health care policy remains underexplored. This study aimed to map publication trends, major contributors, collaboration networks, citation structures, and emerging themes in this field. Methods: A bibliometric analysis was conducted using the Web of Science Core Collection. The search was performed on 3 May 2026, and covered publications from 2000 to 3 May 2026. The final dataset included 347 peer-reviewed English-language original research and review articles. Biblioshiny, VOSviewer, and CiteSpace were used to analyze publication trends, country and institutional contributions, author and journal productivity, collaboration networks, citation and co-citation structures, keyword patterns, and thematic evolution. Results: Publications increased markedly after 2020 and reached their highest annual output in 2025. The 2026 publication count was lower because data for that year were partial at the time of database retrieval. Researchers from 82 countries and 900 institutions contributed to the field, with the United States leading in output, followed by China, England, Canada, and India. Harvard Medical School was the most productive institution, whereas Harvard University had the highest institutional centrality. Frontiers in Public Health published the most articles, and PLOS ONE was the most frequently co-cited journal. The most cited article was “Artificial intelligence and the future of global health.” Key research themes included machine learning, COVID-19, health policy, risk, large language models, interpretable machine learning, neural network-assisted screening, socioeconomic perspectives, and public health applications. Conclusions: Research on artificial intelligence and health care policy has expanded rapidly, particularly in recent years, and is increasingly centered on predictive modeling, public health decision-making, and emerging artificial intelligence technologies. These findings highlight influential contributors, evolving themes, and future directions for researchers, policymakers, and health care leaders.
- 14 July 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (14) , 2103
Open AccessArtificial Intelligence and Healthcare Policy: A Bibliometric Analysis of Global Research Trends
Background: Artificial intelligence is increasingly influencing health care and policy, yet the global research landscape linking artificial intelligence and health care policy remains underexplored. This study aimed to map publication trends, major contributors, collaboration networks, citation structures, and emerging themes in this field. Methods: A bibliometric analysis was conducted using the Web of Science Core Collection. The search was performed on 3 May 2026, and covered publications from 2000 to 3 May 2026. The final dataset included 347 peer-reviewed English-language original research and review articles. Biblioshiny, VOSviewer, and CiteSpace were used to analyze publication trends, country and institutional contributions, author and journal productivity, collaboration networks, citation and co-citation structures, keyword patterns, and thematic evolution. Results: Publications increased markedly after 2020 and reached their highest annual output in 2025. The 2026 publication count was lower because data for that year were partial at the time of database retrieval. Researchers from 82 countries and 900 institutions contributed to the field, with the United States leading in output, followed by China, England, Canada, and India. Harvard Medical School was the most productive institution, whereas Harvard University had the highest institutional centrality. Frontiers in Public Health published the most articles, and PLOS ONE was the most frequently co-cited journal. The most cited article was “Artificial intelligence and the future of global health.” Key research themes included machine learning, COVID-19, health policy, risk, large language models, interpretable machine learning, neural network-assisted screening, socioeconomic perspectives, and public health applications. Conclusions: Research on artificial intelligence and health care policy has expanded rapidly, particularly in recent years, and is increasingly centered on predictive modeling, public health decision-making, and emerging artificial intelligence technologies. These findings highlight influential contributors, evolving themes, and future directions for researchers, policymakers, and health care leaders.
- Open Access
- 8 May 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (19) , e48629
Effects of curcumin on anthropometric measurements in nonalcoholic fatty liver disease: An umbrella meta-analysis study
Background: Metabolic-associated fatty liver disease (MAFLD) affects approximately 30% of the global population and is associated with obesity and metabolic syndrome. Anthropometric indices such as body mass index (BMI), waist circumference (WC), and weight are crucial markers for evaluating the progression of MAFLD. Curcumin, a bioactive compound with anti-inflammatory and antioxidant properties, has been investigated for its potential to improve metabolic outcomes. This umbrella review aimed to systematically evaluate the effects of curcumin supplementation on anthropometric indices in patients with MAFLD, considering epidemiological strength and power analysis. Methods: An umbrella review of meta-analyses from randomized controlled trials was conducted. PubMed, Scopus, and Web of Science were searched up to September 2024. Meta-analyses assessing curcumin’s effects on BMI, weight, and WC in MAFLD patients were included. Quality was assessed using the A Measurement Tool to Assess Systematic Reviews version (AMSTAR-2) tool, and heterogeneity was evaluated using the I 2 statistic. Statistical analyses were performed using R and Stata 18 software. Results: Curcumin supplementation had no significant effect on BMI (standardized mean difference [SMD]: −0.01; 95% confidence interval [CI]: −0.24 to 0.21, P = .91) with low power (1-β = 0.03) and a low epidemiological grade according to GRADE criteria. Similarly, curcumin showed no significant effect on WC (SMD: −0.27; 95% CI: −0.57 to 0.04, P = .08) with high power (1-β = 0.96) but low epidemiological strength. However, curcumin significantly reduced weight (SMD: −0.12; 95% CI: −0.19 to −0.04, P < .01) with moderate power (1-β = 0.56) and moderate epidemiological strength. No significant effect of dose or effect of supplementation duration was found. Conclusion: Curcumin supplementation may result in a statistically detectable but clinically modest reduction in body weight in patients with MAFLD, while showing limited or no efficacy on BMI and waist circumference. The epidemiological strength of the evidence varies across outcomes and is of low to moderate quality. Further well-designed, high-quality randomized controlled trials are needed to confirm the clinical relevance of curcumin’s effects on anthropometric indices.
- 8 May 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (19) , e48629
Open AccessEffects of curcumin on anthropometric measurements in nonalcoholic fatty liver disease: An umbrella meta-analysis study
Background: Metabolic-associated fatty liver disease (MAFLD) affects approximately 30% of the global population and is associated with obesity and metabolic syndrome. Anthropometric indices such as body mass index (BMI), waist circumference (WC), and weight are crucial markers for evaluating the progression of MAFLD. Curcumin, a bioactive compound with anti-inflammatory and antioxidant properties, has been investigated for its potential to improve metabolic outcomes. This umbrella review aimed to systematically evaluate the effects of curcumin supplementation on anthropometric indices in patients with MAFLD, considering epidemiological strength and power analysis. Methods: An umbrella review of meta-analyses from randomized controlled trials was conducted. PubMed, Scopus, and Web of Science were searched up to September 2024. Meta-analyses assessing curcumin’s effects on BMI, weight, and WC in MAFLD patients were included. Quality was assessed using the A Measurement Tool to Assess Systematic Reviews version (AMSTAR-2) tool, and heterogeneity was evaluated using the I 2 statistic. Statistical analyses were performed using R and Stata 18 software. Results: Curcumin supplementation had no significant effect on BMI (standardized mean difference [SMD]: −0.01; 95% confidence interval [CI]: −0.24 to 0.21, P = .91) with low power (1-β = 0.03) and a low epidemiological grade according to GRADE criteria. Similarly, curcumin showed no significant effect on WC (SMD: −0.27; 95% CI: −0.57 to 0.04, P = .08) with high power (1-β = 0.96) but low epidemiological strength. However, curcumin significantly reduced weight (SMD: −0.12; 95% CI: −0.19 to −0.04, P < .01) with moderate power (1-β = 0.56) and moderate epidemiological strength. No significant effect of dose or effect of supplementation duration was found. Conclusion: Curcumin supplementation may result in a statistically detectable but clinically modest reduction in body weight in patients with MAFLD, while showing limited or no efficacy on BMI and waist circumference. The epidemiological strength of the evidence varies across outcomes and is of low to moderate quality. Further well-designed, high-quality randomized controlled trials are needed to confirm the clinical relevance of curcumin’s effects on anthropometric indices.